Subjective and objective outcomes in randomized clinical trials: Definitions differed in methods publications and were often absent from trial reports

Journal of Clinical Epidemiology

Volumn 67, Issue 12, 2014, Pages 1327-1334

  Moustgaard, Helene ^a   Bello, Segun ^a   Miller, Franklin G ^b   Hróbjartsson, Asbjørn ^a  

^a Rigshospitalet   (Denmark)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Endpoints; Objective outcomes; Randomized clinical trials; Risk of bias; Subjective outcomes; Types of outcomes

Indexed keywords

CLASSIFICATION; CLINICAL TRIAL (TOPIC); DATA EXTRACTION; DESCRIPTIVE RESEARCH; EPIDEMIOLOGY; HUMAN; MEDICAL INFORMATION; MEDLINE; METHODOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SCIENTIFIC LITERATURE; SELF REPORT; SYSTEMATIC REVIEW; NOMENCLATURE; PROCEDURES; PUBLISHING; TREATMENT OUTCOME;

HUMANS; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TERMINOLOGY AS TOPIC; TREATMENT OUTCOME;

EID: 84922481776     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2014.06.020     Document Type: Article

References (27)

1. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine - how to practice and teach EBM. New York, NY: Churchill Livingstone; 1997.
2. Savovic J, Jones HE, Altman DG, Harris RJ, Juni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med 2012;157:429-38.
3. Higgins JPT, Green S, Eds. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0, 2011, The Cochrane Collaboration.
4. Friedman LM, Furberg C, DeMets DL. Fundamentals of clinical trials. New York, NY: Springer-Verlag; 2010.
5. Hrobjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Hilden J, Boutron I, et al. Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. BMJ 2012;344:e1119.
6. Wangge G, Klungel OH, Roes KCB, de Boer A, Hoes AW, Knol MJ. Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review. PLoS One 2010;5(10):e13550.
7. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336:601-5.
8. Mendel LL. Objective and subjective hearing aid assessment outcomes. Am J Audiol 2007;16(2):118-29.
9. Jette AM. Measuring subjective clinical outcomes. Phys Ther 1989;69:580-4.
10. Tugwell P, Bombardier C. A methodologic framework for developing and selecting endpoints in clinical trials. J Rheumatol 1982;9:758.
11. Singer AJ, Thode HC Jr, Hollander JE. Research fundamentals: selection and development of clinical outcome measures. Acad Emerg Med 2000;7(4):397-401.
12. Turner RM, Davey J, Clarke MJ, Thompson SG, Higgins JP. Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int J Epidemiol 2012;41:818-27.
13. Krogsgaard K, Gluud C. Valg af effektmål i randomiserede kliniske forsøg [Choice of outcome measures in randomized clinical trials]. Bibliotek for Laeger [Library for Doctors] 1998;190:381-93.
14. Asmar R, Hosseini H. Endpoints in clinical trials: does evidence only originate from 'hard' or mortality endpoints? J Hypertens 2009;27:S45-50.
15. Parfrey PS. Clinical epidemiology, practice and methods. New York, NY: Humana Press; 2009.
16. Devereaux PJ, Manns BJ, Ghali WA, Quan H, Lacchetti C, Montori VM, et al. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA 2001;285:2000-3.
17. Haahr MT, Hrobjartsson A. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors. Clin Trials 2006;3:360-5.
18. Gravel J, Opatrny L, Shapiro S. The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say? Clin Trials 2007;4:350-6.
19. Available at http://www.cochrane.org/glossary. Accessed December 6, 2013.
20. Hrobjartsson A, Gotzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev 2010;(1):CD003974.
21. Hartling L, Hamm MP, Milne A, Vandermeer B, Santaguida PL, Ansari M, et al. Testing the risk of bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs. J Clin Epidemiol 2013;66:973-81.
22. Calvert M, Blazeby J, Altman DG. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA 2013;309:814-22.
23. U.S. Department of Health and Human Services. FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services. FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services. FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006;4(1):79.
24. Gotzsche PC, Liberati A, Torri V, Rosetti L. Beware of surrogate outcome measures. Int J Technol Assess Health Care 1996;12(2):238-46.
25. Hrobjartsson A, Emanuelsson F, Thomsen AS, Hilden J, Brorson S. Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind substudies. Int J Epidemiol 2014;43:1272-83.
26. Hrobjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Hilden J, Boutron I, et al. Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors. CMAJ 2013;185(4):E201-11.
27. Hrobjartsson A, Thomsen ASS, Emanuelsson F, Tendal B, Rasmussen JV, Hilden J, et al. Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. Int J Epidemiol 2014;43:937-48.